Second, the unexpected acceleration in tumor growth observed in TXNIP-overexpressing HCC-1954 cells after four weeks suggests that additional, unknown mechanism(s) may influence TXNIP’s anticancer effects. Here, TXNIP is linked to hepatocellular carcinoma.